𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of cell-mediated lysis by xenoantibodies reactive with effector T lymphocytes

✍ Scribed by Ruth Rabinowitz; Reuven Laskov; Michael Schlesinger

Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
534 KB
Volume
10
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lysis of tumor cells by the retargeting
Lysis of tumor cells by the retargeting of murine cytolytic T lymphocytes with bispecific antibodies
✍ I. G. Barr; H. R. Macdonald; F. Buchegger; V. Von Fliedner 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 652 KB

The specificity and efficiency of tumor-cell lysis by the retargeting of murine cytolytic lymphocytes (CTL) with bispecific antibodies was examined. Bispecific antibodies (also known as heteroaggregated or hybrid antibodies) were produced by the chemical coupling of monoclonal antibodies (MAbs) agai

Inhibition of proliferative and cytotoxi
Inhibition of proliferative and cytotoxic activities of human T lymphocytes with rabbit antibodies directed against leucoagglutinin-reactive T cell surface components
✍ Toini Berzins; Bernt Axelsson; Marie-Louise Hammarström; Sten Hammarström; Peter 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 963 KB

## Inhibition of proliferative and cytotoxic activities of human T lymphocytes with rabbit antibodies directed against leucoagglutinin-reactive T cell surface components * Three rabbit antisera (870, 872 and 873) were raised against leucoagglutinin-reactive components from the surface of human T c

Glycoproteic nature of surface molecules
Glycoproteic nature of surface molecules of effector cells with lymphokine-activated killer (LAK) activity. Evidence that T11, T8 or T3 molecules are not involved in tumor-cell lysis by LAK effector T cells
✍ Marcello Bagnasco; Maria Cristina Mingari; Daniela Pende; Daniela Venuti; Giorgi 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 506 KB

Human peripheral blood mononuclear cells cultured in the presence of interleukin-2 (IL-2) acquire the capability of lysing NK-resistant fresh tumor target cells. in an attempt to (leiin-Isolation and culture of peripheral blood mononuclear cells eate the surface structure(s) present on the effector

Lymphocyte-mediated lysis of tumor cells
Lymphocyte-mediated lysis of tumor cells in vitro (ADCC), induced by serum antibodies from patients with urinary bladder carcinoma or from controls
✍ M. Troye; Y. Hansson; S. Paulie; P. Perlmann; H. Blomgren; B. Johansson 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 694 KB

## Abstract IgG fractions from serum of patients with transitional‐cell carcinoma of the urinary bladder (TCC), patients with carcinoma of the prostate (CC) and healthy donors (HD) were tested for their capacity to induce antibody‐dependent lymphocyte‐mediated cytotoxicity (ADCC) to tumor cells in